ProShare Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,109
| Closed | -$44.8K | – | 2198 |
|
|
2025
Q1 | $44.8K | Sell |
10,109
-2,536
| -20% | -$11.2K | ﹤0.01% | 1964 |
|
|
2024
Q4 | $99K | Buy |
+12,645
| New | +$99K | ﹤0.01% | 2077 |
|
|
2022
Q2 | – | Sell |
-11,069
| Closed | -$132K | – | 2158 |
|
|
2022
Q1 | $132K | Sell |
11,069
-2,710
| -20% | -$32.3K | ﹤0.01% | 1981 |
|
|
2021
Q4 | $224K | Sell |
13,779
-8
| -0.1% | -$130 | ﹤0.01% | 1961 |
|
|
2021
Q3 | $393K | Sell |
13,787
-3,107
| -18% | -$88.6K | ﹤0.01% | 1359 |
|
|
2021
Q2 | $571K | Buy |
16,894
+2,724
| +19% | +$92.1K | ﹤0.01% | 1438 |
|
|
2021
Q1 | $429K | Buy |
14,170
+1,158
| +9% | +$35.1K | ﹤0.01% | 1539 |
|
|
2020
Q4 | $644K | Buy |
13,012
+2,894
| +29% | +$143K | ﹤0.01% | 1111 |
|
|
2020
Q3 | $388K | Sell |
10,118
-305
| -3% | -$11.7K | ﹤0.01% | 1039 |
|
|
2020
Q2 | $450K | Buy |
+10,423
| New | +$450K | ﹤0.01% | 999 |
|
|
2020
Q1 | – | Sell |
-11,795
| Closed | -$369K | – | 1616 |
|
|
2019
Q4 | $369K | Buy |
+11,795
| New | +$369K | ﹤0.01% | 1231 |
|